Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Non-Current Liabilities (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Total Non-Current Liabilities for 14 consecutive years, with $27.6 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 7.53% to $27.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.6 million through Dec 2025, down 7.53% year-over-year, with the annual reading at $27.6 million for FY2025, 7.53% down from the prior year.
  • Total Non-Current Liabilities hit $27.6 million in Q4 2025 for STRATA Skin Sciences, down from $29.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $31.2 million in Q3 2022 to a low of $19.1 million in Q2 2021.
  • Historically, Total Non-Current Liabilities has averaged $26.1 million across 5 years, with a median of $28.2 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 54.64% in 2022 and later fell 9.44% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $21.2 million in 2021, then grew by 4.5% to $22.1 million in 2022, then rose by 27.39% to $28.2 million in 2023, then grew by 5.91% to $29.9 million in 2024, then fell by 7.53% to $27.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for SSKN at $27.6 million in Q4 2025, $29.2 million in Q3 2025, and $28.7 million in Q2 2025.